Innogen Pharmaceutical Launches Efsubaglutide Alfa for Type 2 Diabetes in China
China-based Guangzhou Innogen Pharmaceutical Group Co., Ltd, a biopharma focused on metabolic diseases, announced the...
Intellective Biologics
Intellective Biologics Raises Over RMB500m in Series C Financing Round
China-based macromolecule-focused Contract Development and Manufacturing Organization (CDMO) Intellective Biologics (Suzhou) Co., Ltd has reportedly...